Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.20.2
Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Operating expenses:        
Research and development $ 5,544,000 $ 4,804,076 $ 10,648,441 $ 8,911,216
General and administrative 2,618,797 2,603,403 5,578,697 4,857,996
Total operating expenses 8,162,797 7,407,479 16,227,138 13,769,212
Loss from operations (8,162,797) (7,407,479) (16,227,138) (13,769,212)
Other (expense) income:        
Interest income 25,546 104,441 95,568 253,560
Other expense (2,174,653)   (2,174,653)  
Change in fair value of warrant liabilities (7,305,332) (1,363,868) (6,889,499) 16,435,761
Total other (expense) income (9,454,439) (1,259,427) (8,968,584) 16,689,321
Net (loss) income $ (17,617,236) $ (8,666,906) $ (25,195,722) $ 2,920,109
Basic net (loss) income per share $ (0.88) $ (1.09) $ (1.43) $ 0.37
Shares used in computing basic net (loss) income per share 19,991,894 7,940,931 17,661,968 7,940,931
Diluted net (loss) income per share $ (0.88) $ (1.09) $ (1.43) $ 0.37
Shares used in computing diluted net (loss) income per share 19,991,894 7,940,931 17,661,968 7,945,768